The Asia-Pacific region is experiencing a surge in the nanobody market, reflecting a growing interest in advanced biotechnology. Nanobodies, which are small antigen-binding fragments derived from camelid antibodies, have garnered significant attention due to their numerous advantages over traditional antibodies. In the Asia-Pacific Nanobody Market, the demand for these innovative biologics...